Washington, DC, February 5, 2008 - The American Association for Clinical Chemistry (AACC) presents a conference on Translating Proteomic Discoveries into Clinical Diagnostics to be held May 9-10, 2008 at the Grand Hyatt, Seattle, WA. The conference faculty, which includes global leaders at the forefront of developing proteomic health care technologies, will examine issues surrounding the evolution of proteomics in today’s health care environment. The speakers will outline the areas of greatest opportunity and impact in proteomic discovery applications, as well as technologies designed to aid clinical care.
A special session on international advances in proteomics will feature presenters from Australia, Korea, China and Japan who will highlight proteomic technologies and research being pursued in their respective countries. In addition, the conference will look at some of the ways that proteomic discoveries can be translated into tests suitable for application in clinical laboratories and the impact of new technologies and marker discovery on the future of health care.
The conference’s keynote speaker is Nobel Laureate Leland H. (Lee) Hartwell, PhD, of the Fred Hutchinson Cancer Research Center in Seattle, WA, who will examine the challenges of Creating a Viable Biomarker Pipeline.
AACC invites journalists to register for the conference at no charge by contacting Peter Patterson on (202) 835-8718 or 1-(800) 892-1400 ext 1718. For more information about the conference, including a detailed program, visit the AACC website at Proteomics.